Yun-Xuan Li Selected Research

Chemokine CCL1

10/2021	The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis.
1/2021	The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yun-Xuan Li Research Topics

Disease

3	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2021 - 01/2019
1	Inflammation (Inflammations) 01/2021
1	Fibrosis (Cirrhosis) 01/2019
1	Lung Injury 01/2019
1	Neoplasms (Cancer) 12/2017
1	Colorectal Neoplasms (Colorectal Cancer) 12/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Obesity 01/2017
1	Insulin Resistance 01/2017

Drug/Important Bio-Agent (IBA)

2	Chemokine CCL1IBA 10/2021 - 01/2021
1	EnzymesIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Glycogen Synthase (Synthase I)IBA 01/2019
1	UbiquitinIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	CrizotinibIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	AdipokinesIBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017

Therapy/Procedure

1	Therapeutics 01/2019